New insider activity at Dolby Laboratories ( (DLB) ) has taken place on April 3, 2026.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Director Emily Rollins has trimmed her stake in Dolby Laboratories, selling 1,000 shares of the company’s stock in a transaction valued at $60,080.
Spark’s Take on DLB Stock
According to Spark, TipRanks’ AI Analyst, DLB is a Outperform.
The score is driven primarily by strong financial quality (high margins and very low leverage) and a constructive earnings update with raised FY guidance and visible momentum in strategic licensing areas. Offsetting this are mixed-to-weak technical signals (negative MACD and price below longer-term averages) and a valuation that looks fair-to-slightly expensive given recent TTM growth variability.
To see Spark’s full report on DLB stock, click here.
More about Dolby Laboratories
YTD Price Performance: -3.26%
Average Trading Volume: 786,631
Technical Sentiment Signal: Sell
Current Market Cap: $5.9B